Since inflammation plays a detrimental role in DMD, the high level of IL-1β in the muscles of DMD patients and mdx mice make this pathway an attractive target for reducing the muscle pathology in these affected individuals. Here, IL1B is linked to Duchenne muscular dystrophy.